Dr. Mahmood Piraee, PhD, PharmD
Founder & CEO, Groupe Arex IA Inc. (Operating as Arex AI) • Montréal, Canada
Biography & Professional Background
Dr. Mahmood Piraee, PhD, PharmD is a licensed clinical pharmacist, molecular biologist, and healthcare technology founder. He established Groupe Arex IA Inc. (a Montréal AI health technology startup) to pioneer voice-first companion software for seniors living with chronic illnesses, with a primary focus on age-related macular degeneration.
Dr. Piraee observed firsthand that clinical recommendations (such as daily AREDS2 eye vitamin formulations and high-carotenoid Mediterranean diet intake) frequently fail because older adults with impaired central vision struggle with small medication labels and smartphone screens. Under his leadership, Groupe Arex IA Inc. engineered MacuCoach™ (https://macucoach.com), an empathetic spoken AI companion built using Google Cloud and Gemini.
Clinical Research Leadership
Dr. Piraee is currently leading Groupe Arex IA Inc. in preparing a 12-week clinical feasibility and usability pilot study in collaboration with the American Macular Degeneration Foundation (AMDF). The study will evaluate feasibility, usability, engagement, health-literacy support, and adherence to daily eye-healthy habits among older adults diagnosed with dry age-related macular degeneration.
Direct Contact & Profiles
Primary Email: mpiraee@arexai.ca
Product Email: mpiraee@macucoach.com
LinkedIn: https://www.linkedin.com/in/mahmood-piraee-phd-pharmd-6b3a9117/
Corporate Entity: Groupe Arex IA Inc. | NEQ: 1182501131 | Montréal, Québec, Canada